It's overdue that we take a look at Nuclea Biotechnologies' activities in 2013. Here are some partnerships announced by them this year.
Nuclea Biotechnologies and Wilex Inc Announce Partnership. Nuclea will offer the WILEX Inc IVD serum HER-2/neu ELISA test starting in April. March 20 2013
Wilex are a real company based in Germany, with a genuine product - something Nuclea has never created. Running tests with this assay might lend credibility to the Nuclea story. If you or a relative are offered this test via a Nuclea Laboratory please read this blog thoroughly before deciding to send your sample to them.
PATRICK MURACA, PRESIDENT ; CEO OF NUCLEA BIOTECHNOLOGIES, INC., APPOINTED TO JIMMY FUND VISITING COMMITTEE. - $5.9 million have been given to Dana Farber Cancer Institute in 2013 by Nuclea - he's an obvious pick for their team. Where did the money come from for such a grand donation from a company with zero revenues and which raises money in drips from unnamed investors?
NUCLEA BIOTECHNOLOGIES AND BERKSHIRE MEDICAL CENTER ANNOUNCE RESEARCH AGREEMENT - June 19, 2013 Once again Muraca returns to home territory in Pittsfield and the ever pliable Berkshire Medical Centre for samples.
No comments:
Post a Comment